Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis

Abstract Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead to early recurrence of FSGS and kidney failure after kidney transplantation. In the past three decades, many research endeavors were undertaken to identify these unkn...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Janina Müller-Deile, George Sarau, Ahmed M. Kotb, Christian Jaremenko, Ulrike E. Rolle-Kampczyk, Christoph Daniel, Stefan Kalkhof, Silke H. Christiansen, Mario Schiffer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/66cb9e633c284a039fefd16f2465527e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:66cb9e633c284a039fefd16f2465527e
record_format dspace
spelling oai:doaj.org-article:66cb9e633c284a039fefd16f2465527e2021-12-02T15:54:05ZNovel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis10.1038/s41598-021-83883-w2045-2322https://doaj.org/article/66cb9e633c284a039fefd16f2465527e2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83883-whttps://doaj.org/toc/2045-2322Abstract Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead to early recurrence of FSGS and kidney failure after kidney transplantation. In the past three decades, many research endeavors were undertaken to identify these unknown factors. Even though some potential candidates have been recently discussed in the literature, “the” actual factor remains elusive. Therefore, there is an increased demand in FSGS research for the use of novel technologies that allow us to study FSGS from a yet unexplored angle. Here, we report the successful treatment of recurrent FSGS in a patient after living-related kidney transplantation by removal of circulating factors with CytoSorb apheresis. Interestingly, the classical published circulating factors were all in normal range in this patient but early disease recurrence in the transplant kidney and immediate response to CytoSorb apheresis were still suggestive for pathogenic circulating factors. To proof the functional effects of the patient’s serum on podocytes and the glomerular filtration barrier we used a podocyte cell culture model and a proteinuria model in zebrafish to detect pathogenic effects on the podocytes actin cytoskeleton inducing a functional phenotype and podocyte effacement. We then performed Raman spectroscopy in the < 50 kDa serum fraction, on cultured podocytes treated with the FSGS serum and in kidney biopsies of the same patient at the time of transplantation and at the time of disease recurrence. The analysis revealed changes in podocyte metabolome induced by the FSGS serum as well as in focal glomerular and parietal epithelial cell regions in the FSGS biopsy. Several altered Raman spectra were identified in the fractionated serum and metabolome analysis by mass spectrometry detected lipid profiles in the FSGS serum, which were supported by disturbances in the Raman spectra. Our novel innovative analysis reveals changed lipid metabolome profiles associated with idiopathic FSGS that might reflect a new subtype of the disease.Janina Müller-DeileGeorge SarauAhmed M. KotbChristian JaremenkoUlrike E. Rolle-KampczykChristoph DanielStefan KalkhofSilke H. ChristiansenMario SchifferNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Janina Müller-Deile
George Sarau
Ahmed M. Kotb
Christian Jaremenko
Ulrike E. Rolle-Kampczyk
Christoph Daniel
Stefan Kalkhof
Silke H. Christiansen
Mario Schiffer
Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
description Abstract Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead to early recurrence of FSGS and kidney failure after kidney transplantation. In the past three decades, many research endeavors were undertaken to identify these unknown factors. Even though some potential candidates have been recently discussed in the literature, “the” actual factor remains elusive. Therefore, there is an increased demand in FSGS research for the use of novel technologies that allow us to study FSGS from a yet unexplored angle. Here, we report the successful treatment of recurrent FSGS in a patient after living-related kidney transplantation by removal of circulating factors with CytoSorb apheresis. Interestingly, the classical published circulating factors were all in normal range in this patient but early disease recurrence in the transplant kidney and immediate response to CytoSorb apheresis were still suggestive for pathogenic circulating factors. To proof the functional effects of the patient’s serum on podocytes and the glomerular filtration barrier we used a podocyte cell culture model and a proteinuria model in zebrafish to detect pathogenic effects on the podocytes actin cytoskeleton inducing a functional phenotype and podocyte effacement. We then performed Raman spectroscopy in the < 50 kDa serum fraction, on cultured podocytes treated with the FSGS serum and in kidney biopsies of the same patient at the time of transplantation and at the time of disease recurrence. The analysis revealed changes in podocyte metabolome induced by the FSGS serum as well as in focal glomerular and parietal epithelial cell regions in the FSGS biopsy. Several altered Raman spectra were identified in the fractionated serum and metabolome analysis by mass spectrometry detected lipid profiles in the FSGS serum, which were supported by disturbances in the Raman spectra. Our novel innovative analysis reveals changed lipid metabolome profiles associated with idiopathic FSGS that might reflect a new subtype of the disease.
format article
author Janina Müller-Deile
George Sarau
Ahmed M. Kotb
Christian Jaremenko
Ulrike E. Rolle-Kampczyk
Christoph Daniel
Stefan Kalkhof
Silke H. Christiansen
Mario Schiffer
author_facet Janina Müller-Deile
George Sarau
Ahmed M. Kotb
Christian Jaremenko
Ulrike E. Rolle-Kampczyk
Christoph Daniel
Stefan Kalkhof
Silke H. Christiansen
Mario Schiffer
author_sort Janina Müller-Deile
title Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
title_short Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
title_full Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
title_fullStr Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
title_full_unstemmed Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
title_sort novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/66cb9e633c284a039fefd16f2465527e
work_keys_str_mv AT janinamullerdeile noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT georgesarau noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT ahmedmkotb noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT christianjaremenko noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT ulrikeerollekampczyk noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT christophdaniel noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT stefankalkhof noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT silkehchristiansen noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
AT marioschiffer noveldiagnosticandtherapeutictechniquesrevealchangedmetabolicprofilesinrecurrentfocalsegmentalglomerulosclerosis
_version_ 1718385452393693184